NCT06858163 Coping and Attachment in Pediatric Oncohematology
| NCT ID | NCT06858163 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione IRCCS Policlinico San Matteo di Pavia |
| Condition | Pediatric Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2023-07-12 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2023-07-12 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cancer can be a traumatic and particularly salient experience in a person's history. The ways in which the pediatric patient copes with it depend on the interaction of several factors present in his or her life context, primarily the relationship that is established between parent and child. Despite the paucity of studies in the literature in this regard, it would seem that parental coping is predictive of child coping. Coping strategies represent the ways in which people try to manage traumatic events or stressful everyday situations. Currently, the literature identifies two main categories of coping strategies: emotion-oriented and problem-oriented strategies. The former are aimed on reducing stress-induced unpleasant emotions (e.g., problem avoidance, positive reappraisal, etc.); the latter, on the other hand, focus on stress dissolution/alteration (e.g., problem identification and resolution, stress cause research). Some studies, previously conducted in oncology, show that emotion-focused coping strategies are associated with better adaptation immediately after diagnosis, but their positive influence tends to weaken over time; problem-focused coping strategies are more correlated with poor adaptation immediately after diagnosis, but in the later stages of treatment. The clinical experience with patients in the Pediatric Oncohematology Department brings out the need to develop and structure a psychological assessment model, in order to ensure a more effective care of the family units followed. The research aims, through a single administration of psychological tests, to investigate the role of attachment and some variables (age, gender, stage of treatment, stage of the disease, social support, resilience, ability to adapt to environmental stimuli, emotional state of of caregivers) on the coping strategies implemented by the parents of patients and the patients themselves, in order to differentiate the types of psychological intervention, to try to reduce psychological distress and increase levels of mental well-being.
Eligibility Criteria
Parents Inclusion Criteria: * parents of both sexes * age of son/daughter between 8 and 17 years old (included) * son/daughter being treated at the Pediatric Oncohematology departments involved in the research (Day Hospital and hospitalization) * good understanding of the Italian language Parents Exclusion Criteria: ● son/daughter in off-therapy Patients Inclusion Criteria: * age between 8 and 17 years old (included), undergoing treatment at the Pediatric Oncohematology departments (Day Hospital and hospitalization) * parents enrolled in the study * good understanding of the Italian language Patients Exclusion Criteria: ● patients in off-therapy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06858163 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 17 Years, studying Pediatric Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06858163 currently recruiting?
Yes, NCT06858163 is actively recruiting participants. Contact the research team at m.zecca@smatteo.pv.it for enrollment information.
Where is the NCT06858163 trial being conducted?
This trial is being conducted at Monza, Italy, Pavia, Italy, Taranto, Italy.
Who is sponsoring the NCT06858163 clinical trial?
NCT06858163 is sponsored by Fondazione IRCCS Policlinico San Matteo di Pavia. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.